Cargando…
CT-determined sarcopenia is associated with neutropenia in patients undergoing hyperthermic intraperitoneal chemotherapy for gastrointestinal cancer
BACKGROUND: With better patient selection and the increasing experience in patients undergoing hyperthermic intraperitoneal chemotherapy (HIPEC) combined surgery, the rate of severe postoperative complications and mortality decreased significantly. However, leukopenia and neutropenia were still a pa...
Autores principales: | Jiang, Wei, Zhan, Wenli, He, Fangxun, Wu, Xiaolin, Wu, Jing, Xu, Xiangshang, Cao, Zhixin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945613/ https://www.ncbi.nlm.nih.gov/pubmed/36814253 http://dx.doi.org/10.1186/s12957-023-02950-w |
Ejemplares similares
-
Side-effects of hyperthermic intraperitoneal chemotherapy in patients with gastrointestinal cancers
por: Hu, Jiyun, et al.
Publicado: (2023) -
The importance of primary tumor origin in gastrointestinal malignancies undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Leigh, Natasha, et al.
Publicado: (2020) -
Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study
por: Cashin, Peter H, et al.
Publicado: (2020) -
The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
por: Al Khaldi, Maher, et al.
Publicado: (2022) -
Hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
por: Wu, Tao, et al.
Publicado: (2018)